Gene Techno Collaborates With Kishi Kasei On Aflibercept

Japanese Deal To Jointly Develop A Biosimilar Version Of Eylea

Gene Techno Science and Kishi Kasei have struck a deal to jointly develop a Japanese aflibercept biosimilar rival to Eylea.

Jigsaw
Gene Techno Science and Kishi Kasei will together target a ¥60bn market • Source: Shutterstock

More from Deals

More from Business